Germany · Biotechnology startup
Germany · Emergence Therapeutics
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
Funding reportedLast round: Series A
What company datasets say Emergence Therapeutics raised
Funding, as reported
Reported in all98.1Min the source's currency
Rounds1
Last roundSeries A
Last round dateDec 2021
Investors listed10
Biotechnology in Germany
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Emergence Therapeutics in front of investors. Or tell us what we have wrong.